Closed · RFA-DP-22-002 · CFDA 93.068 · Discretionary
Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts
Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.
- $870K-$900K
- Award range
- Closed
- Status
- January 19, 2022
- Close date
- 6
- Expected awards
The verdict
Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $870,000 -- $900,000 across 6 expected awards. Future funding cycles may be published under the same CFDA number.
- $870K-$900K
- award range
- Closed
- application status
- 6
- expected awards
- 93.068
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts - is cataloged under number RFA-DP-22-002 and tied to CFDA assistance listing 93.068, posted by Centers for Disease Control and Prevention - ERA. Grants.gov currently shows the opportunity as closed, first posted on November 4, 2021 and last updated on January 6, 2022. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is $870,000 -- $900,000. The agency has projected $26.4 million in total estimated funding for this announcement. It expects to issue 6 awards. If the agency funds the expected 6 awards from the $26.4 million estimated pool, the average award works out to roughly $4.4 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on January 19, 2022. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
$870,000 -- $900,000
Close Date
January 19, 2022
Electronically submitted applications must be submitted no later than 5:00pm ET on the listed application due date.
Posted
November 4, 2021
Est. Total Funding
$26,400,000
Expected Awards
6
Instrument
Cooperative Agreement
Description
The primary purpose of this opportunity is to fund applicants with existing access to adult lupus patient populations and can extend current knowledge over 12-17 years from baseline. A second component of this funding opportunity will focus on the pediatric lupus - to advance existing knowledge of lupus in pediatric populations using an existing cohort of lupus patients. Because lupus is a rare condition, it is efficient to obtain new information from existing relevant cohorts with lupus. The research objectives among both adult and pediatric populations are to: Examine the treatment (e.g., medications including opioid; type; appropriateness; etc.) of people with lupus. Determine health care access and gaps that people with lupus experience in addressing their varied health problems (e.g., general health problems as well as those for specific lupus outcomes, such as nephritis; transitions to adulthood). Determine longer term natural history (severity, chronic pain, progression, morbidity, mortality, disability and quality of life, work/ school/activity interference, etc.) of people with lupus, including assessing potential genetic factors. Examine other factors related to disparities in lupus outcomes (e.g., age, sex, and race/ethnic group). Examine lupus comorbidities.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Sue Shaw ResearchNOFO@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Centers for Disease Control and Prevention - ERA
US Travelers Health Research, Surveillance, Communication, and Outreach Network
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Occupational Safety and Health Training Project Grants (T03)
Occupational Safety and Health Education and Research Centers (T42)
RFA-PS-18-000
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |